Skip to content

SNDX

Syndax Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$20.56
−0.58%
Ask drillr
0
Insider buys (3m)
3
Insider sells (3m)
-$2.0M
Net value (3m)
+19.6%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 9, 2026Metzger Michael A · director, officer: Chief Executive OfficerSale32,375$24
Jul 9, 2026Metzger Michael A · director, officer: Chief Executive OfficerM-Exempt32,375$6.38
Jun 12, 2026Botwood Nicholas A.J. · officer: Head of R&D, CMOSale34,280$18
Jun 12, 2026Botwood Nicholas A.J. · officer: Head of R&D, CMOM-Exempt22,515$14
Jun 12, 2026Botwood Nicholas A.J. · officer: Head of R&D, CMOSale31,235$18
Jun 12, 2026Botwood Nicholas A.J. · officer: Head of R&D, CMOM-Exempt31,235$14
Jun 2, 2026Goldan Keith A. · officer: Chief Financial OfficerSale1,177$19
Jun 2, 2026Metzger Michael A · director, officer: Chief Executive OfficerSale6,847$19
Feb 10, 2026Goldan Keith A. · officer: Chief Financial OfficerSale3,410$21
Feb 10, 2026Metzger Michael A · director, officer: Chief Executive OfficerSale17,159$21
Feb 6, 2026Goldan Keith A. · officer: Chief Financial OfficerA-Award118,000$20
Feb 6, 2026Goldan Keith A. · officer: Chief Financial OfficerA-Award21,500$0.00
Feb 6, 2026Jarrett Jennifer · directorA-Award24,000$0.00
Feb 6, 2026Huber Martin H. Jr. · directorA-Award24,000$0.00
Feb 6, 2026Botwood Nicholas A.J. · officer: Head of R&D, CMOA-Award144,700$20
Feb 6, 2026Botwood Nicholas A.J. · officer: Head of R&D, CMOA-Award36,000$0.00
Feb 6, 2026Botwood Nicholas A.J. · officer: Head of R&D, CMOA-Award24,000$0.00
Feb 6, 2026Metzger Michael A · director, officer: Chief Executive OfficerA-Award73,000$0.00
Feb 6, 2026Rizo Aleksandra · directorA-Award24,000$0.00
Feb 6, 2026Metzger Michael A · director, officer: Chief Executive OfficerA-Award144,600$0.00
Feb 6, 2026Metzger Michael A · director, officer: Chief Executive OfficerSale7,412$21
Feb 6, 2026Legault Pierre · directorA-Award24,000$0.00
Feb 6, 2026Metzger Michael A · director, officer: Chief Executive OfficerA-Award440,000$20
Feb 6, 2026Katkin Keith · directorA-Award24,000$0.00
Feb 6, 2026Podlesak Dennis · directorA-Award48,000$0.00
Feb 6, 2026Goldan Keith A. · officer: Chief Financial OfficerA-Award30,750$0.00
Feb 6, 2026Goldan Keith A. · officer: Chief Financial OfficerSale2,082$21
Sep 8, 2025Metzger Michael A · director, officer: Chief Executive OfficerSale157,307$16
Sep 8, 2025Metzger Michael A · director, officer: Chief Executive OfficerM-Exempt157,307$11
Aug 18, 2025Podlesak Dennis · directorSale19,200$14
Institutional positioning

13F filings over the trailing two quarters

New 82Increased 194Reduced 152Sold out 39
FilerActionSharesFiled
BlackRock, Inc.Increased9,020,006Aug 7, 2026
BLACKROCK, INC.Increased8,254,426May 13, 2026
Kynam Capital Management, LPUnchanged8,050,959Aug 14, 2026
KYNAM CAPITAL MANAGEMENT, LPUnchanged8,050,959May 15, 2026
GOLDMAN SACHS GROUP INCIncreased5,861,265Aug 14, 2026
GOLDMAN SACHS GROUP INCIncreased5,695,375Mar 25, 2026
STATE STREET CORPIncreased5,658,424Aug 7, 2026
GOLDMAN SACHS GROUP INCReduced4,996,787May 15, 2026
STATE STREET CORPReduced4,430,076May 15, 2026
BANK OF AMERICA CORP /DE/Reduced4,249,836May 18, 2026
BANK OF AMERICA CORP /DE/Reduced4,045,094Aug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased3,927,892Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position3,822,579May 15, 2026
DEERFIELD MANAGEMENT COMPANY, L.P.Unchanged3,779,900Aug 14, 2026
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)New Position3,779,900May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 9, 2026